CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has released its latest software update; Version 5.0.
The culmination of extensive research, development and feedback from KOLs, Version 5.0 sets a new standard for efficiency, accuracy and simplicity in pre-operative assessment and dry eye management. Packed with cutting-edge features and enhancements, this update promises to revolutionize the way practices manage patient data and standardize dry eye diagnostic testing.
Key Features of CSI Dry Eye Software Version 5.0 Include:
- Expanded Language Support: Responding to the international interest in the software, Version 5.0 introduces support for two additional languages; French and Spanish.
- Enhanced Visuals: Charts have been integrated into assessments to provide more accurate representation of severity levels and conditions, aiding in comprehensive assessment analysis.
- Integrated Medical Intake Form: HIPAA compliant medical intake form sent electronically to patient and integrated back into the software when completed.
- Medication Notification: Proprietary medication alert for drug side effects or issues related to eye disease.
- Referral Center: Clinics can now manage incoming and outgoing referrals as well as add attachments. ($)
- All-New Inbox System: New inbox system features improved navigation for enhanced user experience, customized filtering, notification management, intake form prompts and centralized updates. See immediately when a patient fills out a questionnaire.
- Simplified Assessments: The software now has several pre-operative and dry eye assessment screenings that are easily customized to suit any dry eye clinic and diagnostic testing.
Aftab Ahmad, Chief Technical Officer for CSI Dry Eye Software: “We are thrilled to introduce CSI Dry Eye Software Version 5.0. It represents a significant milestone in our ongoing commitment to revolutionizing dry eye management and diagnosis through technology. With its advanced features and user-centric design, Version 5.0 empowers practitioners to deliver exceptional care, improve patient outcomes and drive operational excellence”.
CSI Dry Eye Software Version 5.0 reaffirms our dedication to innovation and excellence in dry eye AI. This release marks a pivotal moment in the industry as we continue to push the boundaries of what is possible in artificial intelligence and machine learning.
Dr. Ahmed Al-Ghoul, MD, inventor and founder, is speaking this coming weekend at ASCRS in Boston on “Machine Learning Model for Predicting Dry Eye Severity Using ASCRS Pre-Operative OSD Algorithm”. Take in his talk or visit us at booth #2377.
To learn more about CSI Dry Eye Software please visit the website: https://csidryeye.com/